![]() |
||||
| Home : About Us : Contact Us : Search : Site Map | ||||
|
Vaccination ScheduleThe page has been copied from www.hivwebstudy.org: Recommended Adult Immunization Schedule: October 2007-September 2008Annals of Internal Medicine - 20 November 2007 Vaccines & Immunizations - CDC web site Quick Guide - New Adult Immunization Guidelines 2007-2008 Adult Schedule Figures
Recommended Immunizations for HIV-Infected Adults
* Hepatitis B vaccination should be administered to immunocompromised adults at a dose of 40 mcg (3-dose schedule at 0, 1, 6 months if given as Recombivax HB OR 4-dose schedule at 0, 1, 2, 6 months if given as Engerix-B). NOTE: Combination vaccine (hepatitis A & B, Twinrix) is therefore not recommended for immunocompromised individuals. * Varicella vaccination should be considered for HIV-infected children with age-specific CD4+ T-lymphocyte percentage >15% and may be considered for "non-immune" adolescents and adults in with CD4+ T-lymphocyte count >200 cells/L. From:HIV Web Study <http://www.hivwebstudy.org> This table has been reproduced and modified from the ACIP recommendations for routine immunizations of adults with medical conditions. Centers for Disease Control and Prevention: The Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2002-2003 and Recommended Immunizations for adults with medical conditions: United States, 2002-2003. MMWR Recomm Rep. 2002;51(40):904-8. For the full CDC guidelines on vaccinations see: http://www.cdc.gov/mmwr/PDF/rr/rr5102.pdf
*Adobe Acrobat Reader is required for viewing or printing PDFs. Acrobat Reader is available free of charge from the Adobe website at http://www.adobe.com/prodindex/acrobat/readstep.html |
|||
| FOR PATIENTS : FOR PROVIDERS : PHARMACY : CALENDAR : RESOURCES About Us : Contact Us : Search : Site Map : Harborview Medical Center : UW Medical Center |
||||
| Copyright © 2005 University
of Washington. All rights reserved. Notice of Privacy Practices : Copyright and Disclaimer : Credits and Acknowledgements |
||||